Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

124
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
124
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

177
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
177
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

221
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
221
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

419
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
419
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

133
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
133
Survival Tree01:19

Survival Tree

80
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
80

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Robust Modestly Weighted Log-Rank Tests.

Pharmaceutical statistics·2025
Same author

A Bayesian design for dual-agent dose optimization with targeted therapies.

Journal of biopharmaceutical statistics·2025
Same author

Optimal risk-assessment scheduling for primary prevention of cardiovascular disease.

Journal of the Royal Statistical Society. Series A, (Statistics in Society)·2025
Same author

Estimating the Variance of Covariate-Adjusted Estimators of Average Treatment Effects in Clinical Trials With Binary Endpoints.

Pharmaceutical statistics·2025
Same author

Optimal risk assessment intervals for primary prevention of cardiovascular disease: a population-based two-stage landmarking study.

BMJ public health·2025
Same author

Modeling synergism in early phase cancer trials with drug combination with continuous dose levels: is there an added value?

Brazilian journal of biometrics·2024
Same journal

Impact of Information Leakage in Platform Trials With Survival Endpoints on Type I Error Control.

Pharmaceutical statistics·2026
Same journal

Harmonic Fowlkes-Mallows Index for Medical Diagnostics Tests and Optimal Cut-Off Point Selection of Binary Diseases.

Pharmaceutical statistics·2026
Same journal

Early Phase Dose-Finding Designs for CAR-T Cell Therapies.

Pharmaceutical statistics·2026
Same journal

Optimizing Randomization Ratios in Clinical Trials With Survival Endpoints.

Pharmaceutical statistics·2026
Same journal

CUI-MET: A Clinical Utility Index Based Analysis and Decision Framework for Dose Optimization in Multiple-Dose, Multiple-Outcome Randomized Trials.

Pharmaceutical statistics·2026
Same journal

Will the Pharmaceutical Industry Need Statisticians in an AI World?

Pharmaceutical statistics·2026
See all related articles

Related Experiment Video

Updated: Jun 27, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.2K

Visualizing hypothesis tests in survival analysis under anticipated delayed effects.

José L Jiménez1, Isobel Barrott2, Francesca Gasperoni1

  • 1Novartis Pharma A.G., Basel, Switzerland.

Pharmaceutical Statistics
|May 6, 2024
PubMed
Summary
This summary is machine-generated.

Choosing the right statistical method for randomized clinical trials with delayed effects is crucial. This study introduces a graphical approach to compare weighted log-rank tests and Restricted Mean Survival Time (RMST) for better analysis.

Keywords:
delayed effectspseudo‐valuescoresurvival testvisualization

More Related Videos

Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy
07:02

Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy

Published on: January 19, 2019

6.4K
Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions
05:18

Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions

Published on: July 22, 2016

8.4K

Related Experiment Videos

Last Updated: Jun 27, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.2K
Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy
07:02

Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy

Published on: January 19, 2019

6.4K
Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions
05:18

Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions

Published on: July 22, 2016

8.4K

Area of Science:

  • Biostatistics
  • Clinical Trials
  • Survival Analysis

Background:

  • Standard statistical methods like the log-rank test and Cox models may be inadequate for randomized clinical trials (RCTs) with time-to-event endpoints when non-proportional hazards are anticipated due to delayed treatment effects.
  • Recent statistical literature has explored alternative methods, including weighted log-rank tests and tests based on Restricted Mean Survival Time (RMST).

Purpose of the Study:

  • To address the debate on appropriate statistical methods for RCTs with time-to-event data and delayed effects.
  • To introduce a novel graphical approach for comparing different statistical methods.
  • To facilitate a more informed selection of analysis methods beyond traditional power and type I error considerations.

Main Methods:

  • Comparison of weighted log-rank tests and tests based on Restricted Mean Survival Time (RMST).
  • Introduction of a graphical method for direct comparison of these statistical approaches.
  • Evaluation of power and type I error characteristics of different methods under various conditions.

Main Results:

  • Weighted log-rank tests can offer high power but may inflate type I error rates and lack a clear summary measure.
  • RMST-based tests provide a mathematically unambiguous summary measure but may not fully capture long-term treatment benefits.
  • The proposed graphical approach enables a more nuanced comparison of these methods.

Conclusions:

  • The choice of statistical method for RCTs with delayed effects requires careful consideration beyond standard approaches.
  • The graphical comparison tool aids in selecting the most appropriate method based on specific trial characteristics.
  • This work contributes to improving the statistical rigor and interpretation of time-to-event analyses in clinical trials.